Data for: 3D bioprinting patents
Description
This dataset contains information regarding 3D bioprinting patent/patent applications.
Orbit (a fee-based patent database provided by Questel), accessed on Jan. 2, 2022, was used for data mining.
The files titled “3D bioprinting patents” and “Bioink patents” contain information related to Priority, Application and Publication numbers, Priority Application and Publication dates, Title, Abstract, and Current assignees.
The patent searches were carried out by keywords and classification codes.
Both IPC (International Patent Classification) and CPC (Cooperative Patent Classification) codes were used.
Instead of 309 patents (see reference 1), a total number of 3,681 documents were retrieved (of which 3,027 are still alive and 2,461 filed in the period 2016 – 2020).
Most of the published patent applications were generated in China and the USA (1,360 vs 1,063 priority applications). China is effectively the leading country (37%), followed by the USA with 29% of priority patent applications.
Value of the dataset: prior art searches, technological trends
Steps to reproduce data:
The search strategy is reported in the table below:
1 |
857 |
(BIOPRINT+ OR BIOINK? OR ORGAN_ON_A_CHIP)/TI/AB/CLMS/ICLM |
2 |
3096 |
((A61L-027+ OR A61F-002+ OR A61L2430/00) AND (B33Y+ OR B29C-064+))/IPC/CPC |
3 |
3681 |
1 OR 2 |
4 |
71912 |
(C09D-011+)/IPC/CPC |
5 |
104 |
3 AND 4 |
Definition of the classification codes used
A61L 27: Materials for grafts or prostheses or for coating grafts or prostheses
A61F 2: Filters implantable into blood vessels; Prostheses, i.e., artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g., stents
A61L2430/00: Materials or treatment for tissue regeneration
B33Y: Additive manufacturing, i.e., manufacturing of three-dimensional [3-d] objects by additive deposition, additive agglomeration, or additive layering, e.g., by 3-d printing, stereolithography, or selective laser sintering
B29C 64/00: Additive manufacturing, i.e., manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration, or additive layering, e.g., by 3D printing, stereolithography, or selective laser sintering
C09D 11: inks
Files
Key facts of 3D bioprinting patents.png
Files
(1.9 MB)
Name | Size | Download all |
---|---|---|
md5:fa31f4bd804d04f594dda2c40b95cf63
|
1.5 MB | Download |
md5:59238433268c8115fb7def2a48ade289
|
45.3 kB | Download |
md5:b149ac79801ac5d06558d3303837e745
|
159.1 kB | Preview Download |
md5:098c36412f9624cd8d347e7606044f73
|
40.8 kB | Preview Download |
md5:6a98c87bc838775d9c5ab648d392af69
|
80.8 kB | Preview Download |
Additional details
References
- [1] Santoni, S., Gugliandolo, S.G., Sponchioni, M. et al. 3D bioprinting: current status and trends—a guide to the literature and industrial practice. Bio-des. Manuf. (2021). https://doi.org/10.1007/s42242-021-00165-0